Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editors. The substance of the retraction is as follows: Attention has been drawn by Dr Elisabeth Bik to the fact that similar images representing the results of different experiments are shown in Figures 1G and 3F. She also points to the remarkable similarity between the legend text and line graphs of Figure 1 of the Biochimie article, Jia et al (2019), and Figure 1 of a publication in Eur Rev Med Pharmacol Sci (2019), Xu et al (2019). The latter article has since been retracted. An anomymous reader has observed that Figures 1G and 3F show three rows of images shared with Figure 4 of the first-published version of a manuscript in the Journal of the Balkan Union of Oncology (J BUON), Tan et al (2019), submitted and accepted for publication before the submission of the Biochimie article, though it has since publication undergone unexplained modification to Figure 4. Furthermore, the panels shared between the Biochimie and J BUON articles are similar to panels in Figure 7 of a much earlier manuscript, published in October 2017 in Science Reports (Dai et al), as well as to a figure in a later article, Li et al (2020). In addition, the top panel of Figure 3G in Jia et al (2019) as well as the two lower panels is also similar to a part of Figure 7, Dia et al (2017). Further unexplained anomalies concern Figure 3C of Jia et al (2019). The editors would like to thank Dr Bik and the anonymous reader for their valuable insight in this matter. The above observations cast serious doubt on the scientific integrity of the Biochimie article. Confronted with the observation that panels in Figures 1G and 3F were similar though representing different experiments, the authors replied to the editors that the bottom panel in Figure 3F was a mistake and would be corrected. They were not able to produce the raw data when requested, and proposed to the editors to repeat the experiments. However, no new data have been received by the editors at the time of writing, and would not change the serious doubts that they harbour concerning the integrity of the work published in Biochimie. Therefore, the editorial team has opted for retraction irrespective of any new results. This decision has been accepted by the authors.

Retraction Notice to “Mir-650 Regulates the Proliferation, Migration and Invasion of Human Oral Cancer by Targeting Growth Factor Independent 1 (gfi1)” [biochimie 156 (2018) 69–78]

RETRACTED: MiR-650 Regulates the Proliferation, Migration and Invasion of Human Oral Cancer by Targeting Growth Factor Independent 1 (Gfi1).

RETRACTED: Neferine Inhibits Proliferation, Migration and Invasion of U251 Glioma Cells by Down-Regulation of Mir-10B.

Retraction: Cxcl5 Promotes The Proliferation And Migration Of Glioma Cells In Autocrine- And Paracrine-Dependent Manners (Retraction Of Vol 36, Pg 3303, 2016)

RETRACTED: Mir-217 Represses TGF-β1-induced Airway Smooth Muscle Cell Proliferation and Migration Through Targeting ZEB1.

Retraction: Epigenetic Silencing Of Mir-130a Ameliorates Hemangioma By Targeting Tissue Factor Pathway Inhibitor 2 Through Fak/Pi3k/Rac1/Mdm2 Signaling (Retraction Of Vol 50, Pg 1821, 2017)

RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

Retraction notice to “MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5” [Canc. Lett. 322 (2012) 148–158]

Retraction Notice To: Tumor Cell-Secreted Exosomal Mir-22-3p Inhibits Transgelin and Induces Vascular Abnormalization to Promote Tumor Budding

RETRACTED: MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.

RETRACTED: Mir-221/222 Enhance the Tumorigenicity of Human Breast Cancer Stem Cells Via Modulation of PTEN/Akt Pathway

RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3

[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Retraction Note: BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells

RETRACTED: Lncrna PEG10 Promotes Cell Survival, Invasion and Migration by Sponging Mir-134 in Human Bladder Cancer

[Retracted] Tripartite motif‐containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway

Retraction Notice to “iron Chelator-Induced Up-Regulation of Ndrg1 Inhibits Proliferation and EMT Process by Targeting Wnt/β-catenin Pathway in Colon Cancer Cells” [biochem. Biophys. Res. Commun. 506/1 (2018) 114–121]

Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer

[Retracted] Synthetic Mir‑145 Mimic Inhibits Multiple Myeloma Cell Growth in Vitro and in Vivo

Retraction: Talen-Mediated Girdin Knockout Downregulates Cell Proliferation, Migration And Invasion In Human Esophageal Carcinoma Eca109 Cells (Retraction Of Vol 10, Pg 848, 2014)

[Retracted] CXCL5 promotes the proliferation and migration of glioma cells in autocrine‑ and paracrine‑dependent manners